Reagents for Glucagon and Incretin Research (R41/R42)
The summary for the Reagents for Glucagon and Incretin Research (R41/R42) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Reagents for Glucagon and Incretin Research (R41/R42): This Funding Opportunity Announcement (FOA) invites Small Business Innovation Technology Transfer Research (STTR) grant applications from small business concerns (SBCs) in partnership with non-profit research institutions for funding to perform research leading to the development of: A) Validated, highly sensitive, and specific assays for plasma glucagon B) Reagents for manipulation of glucagon receptor activity in the pancreatic islet and other tissues C) Reagents to be used to improve our understanding of pancreatic alpha-cell biology particularly in response to glucagon and incretins D) Reagents and assays for the accurate expression and quantitation of functional incretin receptors in the endocrine/exocrine cells of the pancreas and relevant extrapancreatic tissues.
Federal Grant Title: | Reagents for Glucagon and Incretin Research (R41/R42) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Food and Nutrition Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-14-204 |
Type of Funding: | Grant |
CFDA Numbers: | 93.847 |
CFDA Descriptions: | Diabetes, Digestive, and Kidney Diseases Extramural Research |
Current Application Deadline: | May 7, 2017 |
Original Application Deadline: | May 7, 2017 |
Posted Date: | May 2, 2014 |
Creation Date: | May 2, 2014 |
Archive Date: | Jun 7, 2017 |
Total Program Funding: | |
Maximum Federal Grant Award: | none |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PA-14-204.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogen...
- • Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
- • Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors...
- • NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Requ...
- • NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements...
- • Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
- • Molecular Therapy Core Centers
- • Pilot and Feasibility Program in Human Islet Biology
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)